This Position Statement analyses the barriers in ERN-INdustry interactions, and explains how Together4RD is seeking to move the needle, by learning from case studies, exploring frameworks for collaboration, and launching pilots to explore how best to plan and deliver multistakeholder interactions addressing real research needs.

View this resource Bookmark this resource

Tool 11: Questions people should consider when approaching a new collaboration between ERNs and Industry

Published by

European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug Development

The consultations and outreach activities undertaken by Together4RD over the course of 2024 highlighted certain issues or topics which, whilst ultimately not exactly fitting the brief for this Toolkit (in the sense of there beingexisting tools, or tools Together4RD could prepare alone, for a 2024/5 launch) they nonetheless deserve a mention here as they are very much connected to the overall mission of Together4RD.

View this resource Bookmark this resource

Tool 9: Report on the Experiences and Learnings from the first ERN-Industry pilots supported by Together4RD

Published by

European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug Development

In 2024, the Together4RD Secretariat interviewed key individuals from both Industry and ERNs, about their experiences in launching the first 3 ERN-Industry pilot projects. These interviews were intended to better understand the respective experiences of conceptualizing and initiating these pilots – from who came up with the original idea, to how the project proposals have taken shape, covering activities up to the launch phase (approximately). The main insights are summarized in this Report

View this resource Bookmark this resource

Tool 8: Summary of areas or activities for potential ERN and Industry collaboration

Published by

European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug Development

Stakeholders sometimes struggle to consider the range of activities on which ERNs and Industry could collaborate, besides the more traditional engagement around clinical trials, or more recently, partnering with multiple companies through the European Federation of Pharmaceutical Industries and Associations (EFPIA), in a large project via the Innovative Medicines Initiative, for instance. This resource builds upon material prepared for the comprehensive Together4RD Position Statement, to present a table listing a broad range of potential projects and activities which might be well-suited to ERN and Industry collaboration.

View this resource Bookmark this resource